EU Regulators Schedule December 6 Decision on Novo Holdings’ Acquisition of Catalent

Deadline Set:
The European Commission has set December 6, 2024, as the deadline to decide on the antitrust review of Novo Holdings' proposed acquisition of Catalent.

Acquisition Value:
The deal is valued at $16.5 billion and aims to boost production of Novo Nordisk's products.

Regulatory Process:
EU regulators will assess whether the acquisition complies with antitrust regulations, ensuring fair competition in the market.

Announcement Date:
The decision was announced on November 4, 2024, giving the regulators approximately one month to review the deal.